Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase 1b Study of PD-0332991 in Combination With T-DM1(Trastuzumab-DM1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01976169
Recruitment Status : Active, not recruiting
First Posted : November 5, 2013
Last Update Posted : January 12, 2021
Sponsor:
Collaborators:
Pfizer
University of Pennsylvania
Information provided by (Responsible Party):
Barbara Haley, University of Texas Southwestern Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2021
Estimated Study Completion Date : December 2021